Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Has developed blood clots in one of their eyes just days after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of RETINAL VASCULAR THROMBOSIS (Has developed blood clots in one of their eyes just days after receiving the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) 1 dosage form. In 2021, the patient experienced RETINAL VASCULAR THROMBOSIS (Has developed blood clots in one of their eyes just days after receiving the vaccine) (seriousness criterion medically significant). At the time of the report, RETINAL VASCULAR THROMBOSIS (Has developed blood clots in one of their eyes just days after receiving the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular use) was unknown. Concomitant medication was not reported. Patient took the vaccine and had developed blood clots in one of their eyes just days after receiving the vaccine back in 2021. It was unknown if the patient experienced any additional symptoms/events. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2025-788794 (E2B Linked Report).; Reporter's Comments: Company comment: The benefit-risk relationship of product is not affected by this report.; Sender's Comments: US-MODERNATX, INC.-MOD-2025-788794:Reporter case